Mail

ARWR - Arrowhead Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Currency in USD

Earnings estimate	Current qtr. (Mar 2020)	Next qtr. (Jun 2020)	Current year (2020)	Next year (2021)
No. of analysts	9	9	10	10
Avg. Estimate	-0.11	-0.04	-0.27	-0.62
Low estimate	-0.16	-0.33	-0.81	-1.31
High estimate	0.01	0.57	1.2	0.66
Year ago EPS	0.24	0.21	0.69	-0.27

Revenue estimate	Current qtr. (Mar 2020)	Next qtr. (Jun 2020)	Current year (2020)	Next year (2021)
No. of analysts	10	10	10	10
Avg. Estimate	21.74M	28.66M	107.62M	99.56M
Low estimate	17.8M	N/A	54.45M	40M
High estimate	36M	92.8M	257.8M	231M
Year ago sales	N/A	N/A	168.8M	107.62M
Sales growth (year/est)	N/A	N/A	-36.20%	-7.50%

Earnings history	30/03/2019	29/06/2019	29/09/2019	30/12/2019
Est. EPS	0.19	0.29	0.16	-0.01
Actual EPS	0.24	0.21	0.11	-0.03
Difference	0.05	-0.08	-0.05	-0.02
Surprise %	26.30%	-27.60%	-31.20%	-200.00%

EPS trend	Current qtr. (Mar 2020)	Next qtr. (Jun 2020)	Current year (2020)	Next year (2021)
Current estimate	-0.11	-0.04	-0.27	-0.62
7 days ago	-0.11	-0.07	-0.29	-0.62
30 days ago	-0.11	-0.07	-0.29	-0.57
60 days ago	-0.11	0	-0.17	-0.44
90 days ago	-0.02	0	-0.12	-0.37

EPS revisions	Current qtr. (Mar 2020)	Next qtr. (Jun 2020)	Current year (2020)	Next year (2021)
Up last 7 days	N/A	N/A	1	N/A
Up last 30 days	N/A	N/A	1	N/A
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	N/A	N/A

Growth estimates	ARWR	Industry	Sector	S&P 500
Current qtr.	-145.80%	N/A	N/A	-0.34
Next qtr.	-119.00%	N/A	N/A	-0.12
Current year	-139.10%	N/A	N/A	-0.18
Next year	-129.60%	N/A	N/A	0.26
Next 5 years (per annum)	7.33%	N/A	N/A	0.04
Past 5 years (per annum)	N/A	N/A	N/A	N/A

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more